Leverone Jason A. 4
4 · OnKure Therapeutics, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Leverone Jason A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-27+65,000→ 65,000 totalExercise: $5.19Exp: 2035-01-26→ Class A Common Stock (65,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option shall vest on February 27, 2025 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.